Menu Menu

MDGL    Madrigal Pharmaceuticals Inc    1157601    
Income Statement
Revenue mdgl-20241231 180,133,000
Net Income mdgl-20241231 -465,892,000
Profit Margin -258.64%

Balance Sheet
Current Assets 1,032,927,000
Assets 1,042,247,000
Current Liabilities 169,277,000
Liabilities 287,864,000
Equity 754,383,000
Shares Out 21,713,000

Cash Flow Statement
Operating Cash Flow -455,572,000
Investing Cash Flow -274,386,000

Market Analysis
Market Cap 5,114,202,146
Price 338.14
BVPS 34.74
PB 9.63
EPS -25.50
PS 7.10
FCF -729,958,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/26 -21.90
Apr May Jun
5/07 -7.38
Jul Aug Sep
8/07 -7.10
Oct Nov Dec
10/31 11/06

Find a discrepancy? The most accurate way to find company fundamental data is to view MDGL documents filed with the SEC.


MDGL Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas